Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-021133

Chief Scientific Officer sold 2,696 shares at an average $0.64 ($1,739)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Loose Christopher R. · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-19 Sale : show line 1 in the form 10b5-1 −1,335 $0.65 $868 193,218 D
2023-07-20 Sale : show line 2 in the form 10b5-1 −1,361 $0.64 $871 191,857 D
Open-market sales · 2,696 sh · avg $0.64 · $1,739
Loading xslF345X05/form4.xml…